Gentamycin Sulfate Injection
Gentamycin Sulfate Injection

Gentamycin Sulfate Injection

Specification: 2ml:20mg; 2ml:40mg; 2ml:80mg; 2ml:280mg
Therapeutic indications:
This product is used to treat sepsis, lower respiratory tract infection, intestinal infection, pelvic infection, abdominal infection, skin soft tissue infection, complex urinary tract infection, etc. The combination of gentamicin and other antibacterial drugs is commonly used in clinic. In combination with penicillin (or ampicillin), enterococcal infections are treated. It is also used for central nervous system infection caused by sensitive bacteria, such as meningitis, ventriculitis, can be used at the same time intrathecal injection as an auxiliary treatment.
Send Inquiry

APIS

 

Active Pharmaceutical Ingredient

Latin Name

Molecular Formula

Defination

Structural Formula

Gentamycin Sulfate Injection

Gentamycin Sulfate Iniectio

C(19-21)H(39-43)N5O7·H2SO4

O-2-Amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-a-D-ribo-heptopyranosyl-(1®4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1®6))-2-deoxy-D-streptamine

84

 

Product Specifications

 

Products

Specification

Vomume of vials

Packing form

Gentamycin Sulfate Injection

BP latest version

Colorless to slight yellow or slightly yellowish green, clarity liquid

10amps/tray, 10trays/box

 

Dosage

 

  1. Intramuscular injection or intravenous infusion after dilution for adults, 80mg (80,000 units) once, or 1-1.7mg/kg once per body weight, once every 8 hours; Or 5mg/kg once, once every 24 hours.
  2. Children intramuscular injection or diluted intravenous drip, once 2.5mg/kg, once every 12 hours; Or 1.7mg/kg once every 8 hours. The course of treatment is 7-14 days, during which blood concentration should be monitored as much as possible, especially in newborns or infants.
  3. The dosage of patients with renal dysfunction: according to normal renal function once every 8 hours, a normal dose of 1-1.7mg/kg, creatinine clearance rate of 10-50ml/min, once every 12 hours, a dose of 30-70% of the normal dose; When creatinine clearance is <10ml/min, 20-30% of the normal dose is given every 24-48 hours.
product-344-238
API mixing
product-370-239
Filling
product-367-244
Vial sterilization
Adverse effect

 

Occasionally dizziness, insomnia, lethargy, nausea, diarrhea, constipation, rash, muscle pain and other symptoms. Arrhythmia, elevation of transaminase, changes of renal function, granulocytopenia, etc. may occur when large doses are used.

product-750-1120
product-750-1120
product-750-1120

 

Matters need attention

 

It may cause hearing loss, tinnitus or ear fullness and other ototoxic reactions, affecting vestibular function can occur instability, vertigo. Nephrotoxic reactions such as hematuria, significantly reduced frequency of urination or decreased urine volume, decreased appetite, and extreme thirst may also occur. Low incidence of neuromuscular block or renal toxicity caused by dyspnea, lethargy, weakness and so on. Occasionally, skin rash, nausea, vomiting, hypohepatic function, leukopenia, granulocytopenia, anemia, hypotension, etc. Hearing loss, tinnitus or ear fullness and other ototoxic symptoms may occur in a small number of patients after stopping the drug, which should be noticed. Systemic administration combined with intrathecal injection may cause leg convulsions, rash, fever and general convulsions.

 

Hot Tags: gentamycin sulfate injection, China gentamycin sulfate injection manufacturers, suppliers, factory, Phenoxymethylpenicillin Potassium For Oral Suspension, , Benzathine Penicillin For Injection, lyophilized powder for injection, Ketoprofen For Injection, Vitamin B12 Injection